» Articles » PMID: 10400853

PGE 2 and Dibutyryl Cyclic Adenosine Monophosphate Prolong Eosinophil Survival in Vitro

Overview
Date 1999 Jul 10
PMID 10400853
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Apoptosis represents a mechanism by which the accumulation and inflammatory potential of eosinophils in asthma might be limited. Mediators derived from the airway epithelium may influence the rate of eosinophil apoptosis.

Objective: We have investigated the effects on eosinophil apoptosis of 3 mediators that are likely to be produced by the airway epithelium, namely PGE2, TNF-alpha, and nitric oxide.

Methods: Peripheral blood eosinophils from healthy adult volunteers were purified by density gradient centrifugation and negative immunomagnetic selection. Eosinophils were cultured for 16 or 40 hours with PGE2 (10 nmol/L), dibutyryl cyclic adenosine monophosphate (AMP; 100 micromol/L), TNF-alpha (500 U/mL), the nitric oxide donors, S-nitroso-N-acetylpenicillamine (100 micromol/L), and 2,2;-(hydroxynitrosohydrazono)bis-ethanamine (1 mmol/L), or dibutyryl cyclic guanosine monophosphate (100 micromol/L). Control cultures consisted of untreated, IL5-treated (100 U/mL), and anti-Fas-treated (400 ng/mL) cells. Eosinophil apoptosis was assessed by flow cytometric analysis of annexin V-FITC binding to externalized phosphatidylserine, by electrophoresis of phosphorus 32 end-labeled DNA fragments, and by flow cytometric assessment of hypodiploid DNA with propidium iodide.

Results: PGE2 and cyclic AMP inhibited spontaneous eosinophil apoptosis at both 16 and 40 hours as did the PGEP2 receptor agonist, 11-deoxy PGE1, at 40 hours, but these effects were not inhibited by a protein kinase A antagonist. TNF-alpha delayed apoptosis in eosinophil cultures at 16 hours, whereas S-nitroso- N-acetylpenicillamine, 2, 2;-(hydroxynitrosohydrazono)bis-ethanamine, and cyclic guanosine monophosphate had little effect. Anti-Fas had little effect on spontaneous eosinophil apoptosis but significantly reduced the inhibitory effects of PGE2, cyclic AMP, and TNF-alpha. Assessments of apoptosis by DNA fragmentation gave similar but quantitatively less sensitive results.

Conclusion: Inhibition of spontaneous eosinophil apoptosis by PGE2 appears to be mediated by EP2 receptors but is not protein kinase A dependent. By enhancing eosinophil survival, PGE2 may increase the proinflammatory potential of these cells in chronic asthma.

Citing Articles

Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids.

Knuplez E, Sturm E, Marsche G Int J Mol Sci. 2021; 22(9).

PMID: 33919453 PMC: 8122506. DOI: 10.3390/ijms22094356.


The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy.

Lee K, Lee S, Kim T Int J Mol Sci. 2020; 21(5).

PMID: 32182661 PMC: 7084947. DOI: 10.3390/ijms21051851.


Prostaglandins in asthma and allergic diseases.

Peebles Jr R Pharmacol Ther. 2018; 193:1-19.

PMID: 30081047 PMC: 6309751. DOI: 10.1016/j.pharmthera.2018.08.001.


Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets.

Peinhaupt M, Sturm E, Heinemann A Front Med (Lausanne). 2017; 4:104.

PMID: 28770200 PMC: 5515835. DOI: 10.3389/fmed.2017.00104.


Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets.

Schauberger E, Peinhaupt M, Cazares T, Lindsley A Curr Allergy Asthma Rep. 2016; 16(7):48.

PMID: 27333777 PMC: 5515624. DOI: 10.1007/s11882-016-0628-3.